On October 22, 2016 Managua, the capital of Nicaragua, hosted an official event celebrating the construction completion of Latin America’s first immunobiological vaccine factory – Mechnikov. The ceremony was attended by the Minister of Health of Russia Ms. V.I. Skvortsova, Head of FMBA of Russia Mr. V.V. Uiba, PAHO/WHO Director Ms. Carissa F. Etienne, Director of the Nicaraguan Institute for Social Development Dr. R. Lopez, Director of SPbSRIVS Mr. V.P. Trukhin, and other officials.
The Mechnikov factory was built in just nine months, after the foundation stone was laid by the Minister of Health of Russia Ms. V.I. Skvortsova in the fall of 2015. “A year ago, on October 21, 2015, we laid the foundation stone on the site of the future biomedical biotech facility for the production of seasonal influenza vaccines,” said the minister.
Mechnikov’s production facility with an area of 9,000 sq. m will be one of the most advanced and sophisticated, not only in Latin America, but also globally.
Despite the tight deadlines and the remoteness of the region from Russia, the facility was delivered by the scheduled deadline. That has been made possible by concentrating in a single project Russian technologies and know-how, advanced expertise in the development of the pharmaceutical industry, modern construction technology, and ordering state-of-the-art equipment from the world’s leading vendors.
Mr. Victor Trukhin, Director of SPbSRIVS, commented: “The opening of this facility today has demonstrated to the attending industry professionals that doing business with Russia is a good idea and that, if the negotiations are conducted in the right way, projects like this one can open in a number of countries in the region.”